N/A
N=260
Drug Reduction in Older Patients: The DROP Trial
Geriatric Assessment · Frail Elderly · Skilled Nursing Facilities · Patient-centered Care
Bottom Line
View on ClinicalTrials.gov: NCT03722017 ↗Enrolled (actual)
260
Serious AEs
45.0%
Results posted
Aug 2024
Primary outcome: Primary: Total Number of Medications — 15; 13; 15.5; 14 Medications — p=0.006
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Deprescribing intervention (Other)
- Age
- Adult, Older Adult · 50+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Mar 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Total Number of Medications |
15; 13; 15.5; 14; 15; 12.5 | 0.006 sig |
| SECONDARY Total Drug Burden Index (DBI): Anticholinergic and Sedative Drug Burden |
2.6; 2.6; 2.7; 2.6; 2.3; 2.2 | 0.738 |
Summary
Project Objectives: The proposed randomized, controlled trial will evaluate the effects of procedures to reduce medications among hospitalized older Veterans discharged to nursing homes using an hybrid study design to inform future efforts to spread it across VA.
Project Background/Rationale: Patients discharged to nursing homes for short stays represent the largest group of Medicare beneficiaries discharged to post-hospital services and are a particularly high risk group for loss of independence and other poor clinical outcomes. This investigative team recently completed a VA-funded Quality Improvement Award and a Centers for Medicare and Medicaid Services (CMS) Innovation Award, both of which provide strong results related to the occurrence of polypharmacy and the relationship between polypharmacy and geriatric syndromes (e.g., medications associated with falls) in this patient population. Based on these data, the investigators developed and pilot-tested a patient-centered deprescribing set of procedures combined with standardized questions for eight geriatric syndromes to be implemented in the hospital and monitored during the nursing home stay.
Project Methods: The investigators propose an innovative hybrid study design that will be conducted in one VA hospital. The goal of the proposed DROP intervention is to safely deprescribe medications, as defined by reducing doses or stopping medications, based on a combination of clinical criteria and Veteran preferences. This randomized, controlled trial conducted over three years will evaluate the effects of this hospital-based intervention on medication use, geriatric syndromes, and health status across Veterans' care transitions from the hospital to nursing home to home to include a 90-day follow-up period after leaving the nursing home. The hypothesis is that reducing medications for older Veterans will favorably impact geriatric syndromes. Additionally, the investigators aim to understand Veteran, both VA and non-VA provider and system-level factors that help or hinder how well the deprescribing procedures are implemented to inform future clinical uptake and dissemination throughout the VA.
Eligibility Criteria
Inclusion Criteria
- Referred to SNF (per Physical Therapy and/or Social Work notes)
- Being discharged from the Nashville VA hospital from a medicine or orthopedics team
- Age > or = 50
- Have polypharmacy, as defined by > 5 medications based on pre-hospital and in-hospital medications
- Able to self-consent or has a surrogate
Exclusion Criteria
- Resides in long-term care
- On hospice
- Not expected to discharge within 48 hours of referral
Data sourced from ClinicalTrials.gov (NCT03722017). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.